NCT02673164View on ClinicalTrials.gov

Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Heart Failure
Interventions
BIOLOGICAL

CSCC_ASC

The stem cells will be injected directly into the myocardium using the NOGA XP system (BDS, US)

Trial Locations (1)

2100

2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

European Union

OTHER

lead

JKastrup

OTHER

NCT02673164 - Stem Cell Therapy in IschEmic Non-treatable Cardiac Disease | Biotech Hunter | Biotech Hunter